IBDEI3AH ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,52495,1,3,0)
;;=3^DM Type 2 w/ Diab Nephropathy
;;^UTILITY(U,$J,358.3,52495,1,4,0)
;;=4^E11.21
;;^UTILITY(U,$J,358.3,52495,2)
;;=^5002629
;;^UTILITY(U,$J,358.3,52496,0)
;;=E11.22^^194^2540^3
;;^UTILITY(U,$J,358.3,52496,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52496,1,3,0)
;;=3^DM Type 2 w/ Diab CKD
;;^UTILITY(U,$J,358.3,52496,1,4,0)
;;=4^E11.22
;;^UTILITY(U,$J,358.3,52496,2)
;;=^5002630
;;^UTILITY(U,$J,358.3,52497,0)
;;=E11.39^^194^2540^28
;;^UTILITY(U,$J,358.3,52497,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52497,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Ophth Compl
;;^UTILITY(U,$J,358.3,52497,1,4,0)
;;=4^E11.39
;;^UTILITY(U,$J,358.3,52497,2)
;;=^5002643
;;^UTILITY(U,$J,358.3,52498,0)
;;=E11.41^^194^2540^6
;;^UTILITY(U,$J,358.3,52498,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52498,1,3,0)
;;=3^DM Type 2 w/ Diab Mononeuropathy
;;^UTILITY(U,$J,358.3,52498,1,4,0)
;;=4^E11.41
;;^UTILITY(U,$J,358.3,52498,2)
;;=^5002645
;;^UTILITY(U,$J,358.3,52499,0)
;;=E11.42^^194^2540^13
;;^UTILITY(U,$J,358.3,52499,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52499,1,3,0)
;;=3^DM Type 2 w/ Diab Polyneuropathy
;;^UTILITY(U,$J,358.3,52499,1,4,0)
;;=4^E11.42
;;^UTILITY(U,$J,358.3,52499,2)
;;=^5002646
;;^UTILITY(U,$J,358.3,52500,0)
;;=E11.43^^194^2540^2
;;^UTILITY(U,$J,358.3,52500,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52500,1,3,0)
;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
;;^UTILITY(U,$J,358.3,52500,1,4,0)
;;=4^E11.43
;;^UTILITY(U,$J,358.3,52500,2)
;;=^5002647
;;^UTILITY(U,$J,358.3,52501,0)
;;=E11.44^^194^2540^1
;;^UTILITY(U,$J,358.3,52501,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52501,1,3,0)
;;=3^DM Type 2 w/ Diab Amyotrophy
;;^UTILITY(U,$J,358.3,52501,1,4,0)
;;=4^E11.44
;;^UTILITY(U,$J,358.3,52501,2)
;;=^5002648
;;^UTILITY(U,$J,358.3,52502,0)
;;=E11.49^^194^2540^8
;;^UTILITY(U,$J,358.3,52502,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52502,1,3,0)
;;=3^DM Type 2 w/ Diab Neurological Compl
;;^UTILITY(U,$J,358.3,52502,1,4,0)
;;=4^E11.49
;;^UTILITY(U,$J,358.3,52502,2)
;;=^5002649
;;^UTILITY(U,$J,358.3,52503,0)
;;=E11.59^^194^2540^25
;;^UTILITY(U,$J,358.3,52503,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52503,1,3,0)
;;=3^DM Type 2 w/ Oth Circulatory Compl
;;^UTILITY(U,$J,358.3,52503,1,4,0)
;;=4^E11.59
;;^UTILITY(U,$J,358.3,52503,2)
;;=^5002652
;;^UTILITY(U,$J,358.3,52504,0)
;;=E11.610^^194^2540^9
;;^UTILITY(U,$J,358.3,52504,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52504,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,52504,1,4,0)
;;=4^E11.610
;;^UTILITY(U,$J,358.3,52504,2)
;;=^5002653
;;^UTILITY(U,$J,358.3,52505,0)
;;=E11.618^^194^2540^26
;;^UTILITY(U,$J,358.3,52505,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52505,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Arthropathy
;;^UTILITY(U,$J,358.3,52505,1,4,0)
;;=4^E11.618
;;^UTILITY(U,$J,358.3,52505,2)
;;=^5002654
;;^UTILITY(U,$J,358.3,52506,0)
;;=E11.621^^194^2540^16
;;^UTILITY(U,$J,358.3,52506,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52506,1,3,0)
;;=3^DM Type 2 w/ Foot Ulcer
;;^UTILITY(U,$J,358.3,52506,1,4,0)
;;=4^E11.621
;;^UTILITY(U,$J,358.3,52506,2)
;;=^5002656
;;^UTILITY(U,$J,358.3,52507,0)
;;=E11.622^^194^2540^31
;;^UTILITY(U,$J,358.3,52507,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52507,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Ulcer
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3AH 3773 printed Apr 09, 2024@21:56:17 Page 2
IBDEI3AH ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,52495,1,3,0)
+2 ;;=3^DM Type 2 w/ Diab Nephropathy
+3 ;;^UTILITY(U,$J,358.3,52495,1,4,0)
+4 ;;=4^E11.21
+5 ;;^UTILITY(U,$J,358.3,52495,2)
+6 ;;=^5002629
+7 ;;^UTILITY(U,$J,358.3,52496,0)
+8 ;;=E11.22^^194^2540^3
+9 ;;^UTILITY(U,$J,358.3,52496,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,52496,1,3,0)
+12 ;;=3^DM Type 2 w/ Diab CKD
+13 ;;^UTILITY(U,$J,358.3,52496,1,4,0)
+14 ;;=4^E11.22
+15 ;;^UTILITY(U,$J,358.3,52496,2)
+16 ;;=^5002630
+17 ;;^UTILITY(U,$J,358.3,52497,0)
+18 ;;=E11.39^^194^2540^28
+19 ;;^UTILITY(U,$J,358.3,52497,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,52497,1,3,0)
+22 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
+23 ;;^UTILITY(U,$J,358.3,52497,1,4,0)
+24 ;;=4^E11.39
+25 ;;^UTILITY(U,$J,358.3,52497,2)
+26 ;;=^5002643
+27 ;;^UTILITY(U,$J,358.3,52498,0)
+28 ;;=E11.41^^194^2540^6
+29 ;;^UTILITY(U,$J,358.3,52498,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,52498,1,3,0)
+32 ;;=3^DM Type 2 w/ Diab Mononeuropathy
+33 ;;^UTILITY(U,$J,358.3,52498,1,4,0)
+34 ;;=4^E11.41
+35 ;;^UTILITY(U,$J,358.3,52498,2)
+36 ;;=^5002645
+37 ;;^UTILITY(U,$J,358.3,52499,0)
+38 ;;=E11.42^^194^2540^13
+39 ;;^UTILITY(U,$J,358.3,52499,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,52499,1,3,0)
+42 ;;=3^DM Type 2 w/ Diab Polyneuropathy
+43 ;;^UTILITY(U,$J,358.3,52499,1,4,0)
+44 ;;=4^E11.42
+45 ;;^UTILITY(U,$J,358.3,52499,2)
+46 ;;=^5002646
+47 ;;^UTILITY(U,$J,358.3,52500,0)
+48 ;;=E11.43^^194^2540^2
+49 ;;^UTILITY(U,$J,358.3,52500,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,52500,1,3,0)
+52 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
+53 ;;^UTILITY(U,$J,358.3,52500,1,4,0)
+54 ;;=4^E11.43
+55 ;;^UTILITY(U,$J,358.3,52500,2)
+56 ;;=^5002647
+57 ;;^UTILITY(U,$J,358.3,52501,0)
+58 ;;=E11.44^^194^2540^1
+59 ;;^UTILITY(U,$J,358.3,52501,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,52501,1,3,0)
+62 ;;=3^DM Type 2 w/ Diab Amyotrophy
+63 ;;^UTILITY(U,$J,358.3,52501,1,4,0)
+64 ;;=4^E11.44
+65 ;;^UTILITY(U,$J,358.3,52501,2)
+66 ;;=^5002648
+67 ;;^UTILITY(U,$J,358.3,52502,0)
+68 ;;=E11.49^^194^2540^8
+69 ;;^UTILITY(U,$J,358.3,52502,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,52502,1,3,0)
+72 ;;=3^DM Type 2 w/ Diab Neurological Compl
+73 ;;^UTILITY(U,$J,358.3,52502,1,4,0)
+74 ;;=4^E11.49
+75 ;;^UTILITY(U,$J,358.3,52502,2)
+76 ;;=^5002649
+77 ;;^UTILITY(U,$J,358.3,52503,0)
+78 ;;=E11.59^^194^2540^25
+79 ;;^UTILITY(U,$J,358.3,52503,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,52503,1,3,0)
+82 ;;=3^DM Type 2 w/ Oth Circulatory Compl
+83 ;;^UTILITY(U,$J,358.3,52503,1,4,0)
+84 ;;=4^E11.59
+85 ;;^UTILITY(U,$J,358.3,52503,2)
+86 ;;=^5002652
+87 ;;^UTILITY(U,$J,358.3,52504,0)
+88 ;;=E11.610^^194^2540^9
+89 ;;^UTILITY(U,$J,358.3,52504,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,52504,1,3,0)
+92 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
+93 ;;^UTILITY(U,$J,358.3,52504,1,4,0)
+94 ;;=4^E11.610
+95 ;;^UTILITY(U,$J,358.3,52504,2)
+96 ;;=^5002653
+97 ;;^UTILITY(U,$J,358.3,52505,0)
+98 ;;=E11.618^^194^2540^26
+99 ;;^UTILITY(U,$J,358.3,52505,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,52505,1,3,0)
+102 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
+103 ;;^UTILITY(U,$J,358.3,52505,1,4,0)
+104 ;;=4^E11.618
+105 ;;^UTILITY(U,$J,358.3,52505,2)
+106 ;;=^5002654
+107 ;;^UTILITY(U,$J,358.3,52506,0)
+108 ;;=E11.621^^194^2540^16
+109 ;;^UTILITY(U,$J,358.3,52506,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,52506,1,3,0)
+112 ;;=3^DM Type 2 w/ Foot Ulcer
+113 ;;^UTILITY(U,$J,358.3,52506,1,4,0)
+114 ;;=4^E11.621
+115 ;;^UTILITY(U,$J,358.3,52506,2)
+116 ;;=^5002656
+117 ;;^UTILITY(U,$J,358.3,52507,0)
+118 ;;=E11.622^^194^2540^31
+119 ;;^UTILITY(U,$J,358.3,52507,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,52507,1,3,0)
+122 ;;=3^DM Type 2 w/ Oth Skin Ulcer
